NCT04490733 Developing Risk Prediction Model and Testing the Effect of Dual Task Walking on Improving Cognitive Function in Patients With Colorectal Cancer
| NCT ID | NCT04490733 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 355 participants |
| Start Date | 2020-08-17 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 355 participants in total. It began in 2020-08-17 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aims of this three-year study are to explore cognitive function under different stages of colorectal cancer (CRC) and its related factors; and understand its disturbance and coping process caused by cancer-induced cognitive impairment (CICI) from patient perspective; and further to test effect of dual-task walking on improving cognitive function in CRC patients.
Eligibility Criteria
Inclusion Criteria: * Patients with newly diagnosed stage I to III colorectal cancer. Exclusion Criteria: * Patients with cancer other than colorectal cancer or have cancer recurrence.
Contact & Investigator
Shiow-Ching Shun, PHD
STUDY CHAIR
National Taiwan University
Frequently Asked Questions
Who can join the NCT04490733 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 75 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04490733 currently recruiting?
Yes, NCT04490733 is actively recruiting participants. Contact the research team at scshun@ntu.edu.tw for enrollment information.
Where is the NCT04490733 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT04490733 clinical trial?
NCT04490733 is sponsored by National Taiwan University Hospital. The principal investigator is Shiow-Ching Shun, PHD at National Taiwan University. The trial plans to enroll 355 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.